09:15 AM EDT, 04/08/2026 (MT Newswires) -- Health care stocks were advancing premarket Wednesday, with the iShares Biotechnology ETF (IBB) up 2.3% and the State Street Health Care Select Sector SPDR ETF ( XLV ) 1.5% higher.

GSK (GSK) shares were up more than 2% after the company said the Chinese National Medical Products Administration approved its biologic medication Exdensur as a supplemental therapy for adult patients suffering from chronic rhinosinusitis with nasal polyps.

Becton, Dickinson ( BDX ) stock was up more than 1% after the company said it has applied for a CE Mark in the European Union for its Liverty TIPS Stent Graft, a next-generation device designed to treat complications from portal hypertension in the liver.

Bausch + Lomb ( BLCO ) shares were up more than 3% after the company said the US Food and Drug Administration cleared its advanced dual-port vitrectomy cutter and a fluidics software update for its vision enhancement system, used for retinal surgery.